Caprock Group, Inc. Merck & Co., Inc. Transaction History

Caprock Group, Inc.

  • $3 Billion
  • Q4 2024

A detailed history of Caprock Group, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Caprock Group, Inc. holds 70,648 shares of MRK stock, worth $6.17 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
70,648
Previous 69,075 2.28%
Holding current value
$6.17 Million
Previous $7.84 Million 10.4%
% of portfolio
0.23%
Previous 0.29%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 23, 2025
BUY
$96.31 - $114.76 $151,495 - $180,517
1,573 Added 2.28%
70,648 $7.03 Million
Q3 2024

Nov 07, 2024
SELL
$111.15 - $128.97 $321,779 - $373,368
-2,895 Reduced 4.02%
69,075 $7.84 Million
Q2 2024

Aug 06, 2024
BUY
$123.8 - $132.96 $2.59 Million - $2.78 Million
20,927 Added 41.0%
71,970 $8.91 Million
Q1 2024

Apr 29, 2024
BUY
$113.24 - $131.95 $271,549 - $316,416
2,398 Added 4.93%
51,043 $6.74 Million
Q4 2023

Jan 18, 2024
BUY
$100.18 - $109.02 $1.6 Million - $1.74 Million
15,922 Added 48.66%
48,645 $5.3 Million
Q3 2023

Oct 18, 2023
BUY
$102.95 - $114.33 $117,568 - $130,564
1,142 Added 3.62%
32,723 $3.37 Million
Q2 2023

Aug 10, 2023
BUY
$108.61 - $118.38 $233,077 - $254,043
2,146 Added 7.29%
31,581 $3.64 Million
Q1 2023

Apr 26, 2023
BUY
$102.94 - $114.86 $75,455 - $84,192
733 Added 2.55%
29,435 $3.13 Million
Q4 2022

Jan 23, 2023
BUY
$87.44 - $112.11 $187,209 - $240,027
2,141 Added 8.06%
28,702 $0
Q3 2022

Nov 07, 2022
BUY
$84.53 - $94.96 $75,569 - $84,894
894 Added 3.48%
26,561 $2.31 Million
Q2 2022

Jul 26, 2022
BUY
$83.49 - $94.64 $84,241 - $95,491
1,009 Added 4.09%
25,667 $2.36 Million
Q1 2022

Apr 12, 2022
BUY
$73.51 - $82.4 $115,998 - $130,027
1,578 Added 6.84%
24,658 $2.04 Million
Q4 2021

Jan 18, 2022
SELL
$72.28 - $90.54 $879,430 - $1.1 Million
-12,167 Reduced 34.52%
23,080 $1.79 Million
Q3 2021

Oct 07, 2021
SELL
$71.68 - $78.83 $2,652 - $2,916
-37 Reduced 0.1%
35,247 $2.67 Million
Q2 2021

Aug 13, 2021
BUY
$70.31 - $77.77 $351,057 - $388,305
4,993 Added 16.48%
35,284 $2.77 Million
Q1 2021

Apr 29, 2021
SELL
$68.86 - $81.11 $498,615 - $587,317
-7,241 Reduced 19.29%
30,291 $2.36 Million
Q4 2020

Jan 29, 2021
BUY
$71.77 - $79.65 $269,783 - $299,404
3,759 Added 11.13%
37,532 $3.1 Million
Q3 2020

Oct 29, 2020
SELL
$73.18 - $82.95 $48,737 - $55,244
-666 Reduced 1.93%
33,773 $2.82 Million
Q2 2020

Aug 05, 2020
BUY
$70.42 - $80.13 $273,159 - $310,824
3,879 Added 12.69%
34,439 $2.68 Million
Q1 2020

Apr 28, 2020
BUY
$63.36 - $87.82 $897,874 - $1.24 Million
14,171 Added 86.47%
30,560 $2.37 Million
Q4 2019

Feb 04, 2020
SELL
$77.58 - $87.54 $8,533 - $9,629
-110 Reduced 0.67%
16,389 $1.5 Million
Q3 2019

Oct 31, 2019
BUY
$76.08 - $82.93 $96,393 - $105,072
1,267 Added 8.32%
16,499 $1.4 Million
Q2 2019

Jul 23, 2019
SELL
$69.84 - $81.59 $712,018 - $831,810
-10,195 Reduced 40.1%
15,232 $1.29 Million
Q1 2019

Apr 12, 2019
BUY
$69.58 - $79.36 $181,534 - $207,050
2,609 Added 11.43%
25,427 $2.13 Million
Q4 2018

Jan 29, 2019
BUY
$65.24 - $75.71 $175,626 - $203,811
2,692 Added 13.38%
22,818 $1.76 Million
Q3 2018

Oct 17, 2018
SELL
$57.69 - $67.84 $30,287 - $35,616
-525 Reduced 2.54%
20,126 $1.44 Million
Q2 2018

Jul 23, 2018
SELL
$50.83 - $59.72 $518,313 - $608,964
-10,197 Reduced 33.06%
20,651 $1.26 Million
Q1 2018

Apr 23, 2018
SELL
$50.96 - $59.23 $174,283 - $202,566
-3,420 Reduced 9.98%
30,848 $1.7 Million
Q4 2017

Jan 17, 2018
SELL
$51.62 - $61.64 $310,545 - $370,826
-6,016 Reduced 14.93%
34,268 $2.01 Million
Q3 2017

Oct 23, 2017
BUY
$58.67 - $63.13 $2.36 Million - $2.54 Million
40,284
40,284 $2.6 Million

Others Institutions Holding MRK

# of Institutions
3,859
Shares Held
1.89B
Call Options Held
15.6M
Put Options Held
13.6M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $221B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Caprock Group, Inc. Portfolio

Follow Caprock Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Caprock Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email